Market By Application, Route Of Administration, End-user And Country | Forecast 2019-2028
Triton Market Research’s report on the Latin American clinical nutrition market determines that it is set to flourish at a CAGR of 4.36%, in terms of revenue, during the forecasted period 2019-2028.
Report scope can be customized per your requirements. Request For Customization
The countries reviewed in the Latin American clinical nutrition market are:
• Mexico
• Brazil
• Rest of Latin America
The clinical nutrition market in Latin America is witnessing rapid growth owing to the rising incidence of diseases related to malnutrition, several government initiatives and growth in in-home healthcare. In 2018, about 29.6 million people were diagnosed with diabetes in the region, and is expected to reach 48.8 million by the year 2040. The region is also experiencing an increased prevalence of stomach cancer among patients under the age of 40. The rising diabetic population, along with the increasing occurrence of cancer in countries like Brazil, Mexico and Argentina, are is another factor expected to drive the clinical nutrition market in the region.
In Brazil, the rate of preterm births is more than 12% of the total births, which is higher than the global average of 10%. Complications due to preterm birth are some of the most common direct causes of death in children of less than five years of age. The government is implementing several initiatives, including reimbursement on enteral nutrition, which is also driving the market growth. The Brazilian Society for Food and Nutrition Board approved a statement on nutrigenetic tests to enhance the clinical nutrition system in Brazil. All these factors are estimated to aid the studied market growth in the upcoming years.
Nestle SA is a health and wellness company. It operates in approximately 190 countries across different regions, including Latin America. Peptamen Intense is a supplement provided by the company that increases protein provision without increasing caloric intake. It also offers other products, including Peptamen Af, Peptamen HN, Isosource and Peptamen 1.0.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT
1. LATIN AMERICA CLINICAL NUTRITION MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. PORTER’S FIVE FORCES MODEL
2.2.1. THREAT OF NEW ENTRANTS
2.2.2. THREAT OF SUBSTITUTE PRODUCTS
2.2.3. BARGAINING POWER OF BUYERS
2.2.4. BARGAINING POWER OF SUPPLIERS
2.2.5. COMPETITIVE RIVALRY
2.3. IMPACT OF COVID-19 ON CLINICAL NUTRITION MARKET
2.4. MARKET ATTRACTIVENESS INDEX
2.5. VENDOR SCORECARD
2.6. KEY INSIGHTS
2.7. MARKET DRIVERS
2.7.1. INCREASING NUMBER OF PEOPLE SUFFERING FROM CHRONIC HEALTH DISEASES
2.7.2. SURGING NUMBER OF MALNUTRITION VICTIMS
2.8. MARKET RESTRAINTS
2.8.1. DIFFICULTIES RELATED TO ENTERAL FEEDING
2.8.2. LACK OF AWARENESS REGARDING CLINICAL NUTRITION
2.9. MARKET OPPORTUNITIES
2.9.1. GROWING AGING POPULATION
2.9.2. RISING USAGE OF CLINICAL NUTRITION IN DEVELOPING COUNTRIES
2.10. MARKET CHALLENGES
2.10.1. STRINGENT REGULATORY FRAMEWORK
2.10.2. FALSE PERCEPTIONS ASSOCIATED WITH MALNUTRITION
3. CLINICAL NUTRITION MARKET OUTLOOK - BY APPLICATION
3.1. CANCER
3.2. NEUROLOGICAL DISEASES
3.3. GASTROINTESTINAL DISORDERS
3.4. METABOLIC DISORDERS
3.5. OTHER APPLICATIONS
4. CLINICAL NUTRITION MARKET OUTLOOK - BY ROUTE OF ADMINISTRATION
4.1. ORAL
4.2. ENTERAL
4.3. PARENTERAL
5. CLINICAL NUTRITION MARKET OUTLOOK - BY END-USER
5.1. PEDIATRIC
5.2. GERIATRIC
5.3. ADULTS
6. CLINICAL NUTRITION MARKET – LATIN AMERICA
6.1. BRAZIL
6.2. MEXICO
6.3. REST OF LATIN AMERICA
7. COMPANY PROFILES
7.1. NESTLE HEALTH SCIENCE
7.2. BASF SE
7.3. AVADEL PHARMACEUTICALS
7.4. MEIJI HOLDINGS CO LTD
7.5. BAXTER INTERNATIONAL INC
7.6. RECKITT BENCKISER GROUP PLC
7.7. B BRAUN
7.8. SANOFI SA
7.9. AMERICAN REGENT INC
7.10. OTSUKA HOLDINGS CO LTD
7.11. ABBOTT LABORATORIES
7.12. SICHUAN KELUN PHARMACEUTICAL CO LTD
7.13. LONZA INC
7.14. DANONE
7.15. GRIFOLS SA
7.16. EXELA PHARMA SCIENCES
8. RESEARCH METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE & DELIVERABLES
8.1.1. OBJECTIVES OF STUDY
8.1.2. SCOPE OF STUDY
8.2. SOURCES OF DATA
8.2.1. PRIMARY DATA SOURCES
8.2.2. SECONDARY DATA SOURCES
8.3. RESEARCH METHODOLOGY
8.3.1. EVALUATION OF PROPOSED MARKET
8.3.2. IDENTIFICATION OF DATA SOURCES
8.3.3. ASSESSMENT OF MARKET DETERMINANTS
8.3.4. DATA COLLECTION
8.3.5. DATA VALIDATION & ANALYSIS
TABLE 1 LATIN AMERICA CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)
TABLE 2 VENDOR SCORECARD
TABLE 3 LATIN AMERICA CLINICAL NUTRITION MARKET, BY APPLICATION, 2019-2028 (IN $ MILLION)
TABLE 4 LATIN AMERICA CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (IN $ MILLION)
TABLE 5 LATIN AMERICA CLINICAL NUTRITION MARKET, BY END-USER, 2019-2028 (IN $ MILLION)
TABLE 6 LATIN AMERICA CLINICAL NUTRITION MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
FIGURE 1 LATIN AMERICA CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)
FIGURE 2 DIFFICULTIES ASSOCIATED WITH ENTERAL FEEDING
FIGURE 3 LATIN AMERICA CLINICAL NUTRITION MARKET, BY CANCER, 2019-2028 (IN $ MILLION)
FIGURE 4 LATIN AMERICA CLINICAL NUTRITION MARKET, BY NEUROLOGICAL DISEASES, 2019-2028 (IN $ MILLION)
FIGURE 5 LATIN AMERICA CLINICAL NUTRITION MARKET, BY GASTROINTESTINAL DISORDERS, 2019-2028 (IN $ MILLION)
FIGURE 6 LATIN AMERICA CLINICAL NUTRITION MARKET, BY METABOLIC DISORDERS, 2019-2028 (IN $ MILLION)
FIGURE 7 LATIN AMERICA CLINICAL NUTRITION MARKET, BY OTHER APPLICATIONS, 2019-2028 (IN $ MILLION)
FIGURE 8 LATIN AMERICA CLINICAL NUTRITION MARKET, BY ORAL, 2019-2028 (IN $ MILLION)
FIGURE 9 LATIN AMERICA CLINICAL NUTRITION MARKET, BY ENTERAL, 2019-2028 (IN $ MILLION)
FIGURE 10 LATIN AMERICA CLINICAL NUTRITION MARKET, BY PARENTERAL, 2019-2028 (IN $ MILLION)
FIGURE 11 LATIN AMERICA CLINICAL NUTRITION MARKET, BY PEDIATRIC, 2019-2028 (IN $ MILLION)
FIGURE 12 LATIN AMERICA CLINICAL NUTRITION MARKET, BY GERIATRIC, 2019-2028 (IN $ MILLION)
FIGURE 13 LATIN AMERICA CLINICAL NUTRITION MARKET, BY ADULTS, 2019-2028 (IN $ MILLION)
FIGURE 14 BRAZIL CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)
FIGURE 15 MEXICO CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)
FIGURE 16 REST OF LATIN AMERICA CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)